Jubilant Biosys, a subsidiary of Jubilant Organosys, has developed a next-generation screening solution, Legend NGSS, to further enable the process of high-throughput screening.
The software, to be launched in the US and Europe initially, allows scientists to capture, store and analyse Oracle 9i/10g based screening data with greater flexibility, accuracy and speed.
Legend NGSS allows users to create rich visualisation and interactive analysis reports, including dose-response curves and scatter plot heat maps.
The tool allows flexible and interactive mother to daughter plate mapping from any plate reader.
This generates best-fit kinetic and time course assays, without internal IT intervention, complete management of compound and targeted libraries, and optimised on-the-fly curve-fitting techniques.
Legend NGSS has been developed in collaboration with a leading global pharmaceutical company.
It is available worldwide on a subscription basis, which includes software support and training.
